Ironwood Pharmaceuticals, Inc. (IRWD)

Ironwood Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	92.15	657.45	621.38	364.3	178.27
Cash & Cash Equivalents	92.15	657.45	621.38	364.3	178.27
Cash Growth	-85.98%	5.81%	70.57%	104.35%	2.21%
Receivables	129.12	130.05	138.04	145.75	149.84
Inventory	0	0	0	0	0.65
Other Current Assets	12.01	-6.87	-14.19	-14.21	-21.91
Total Current Assets	233.29	780.63	745.23	495.84	306.85
Property, Plant & Equipment	18.17	20.31	22.93	25.51	30.17
Long-Term Investments	0	0.49	0.49	0.49	0.97
Goodwill and Intangibles	3.68	0	0	0	0
Other Long-Term Assets	215.93	299.1	358.29	37.41	64.75
Total Long-Term Assets	237.79	319.89	381.7	63.4	95.9
Total Assets	471.07	1,101	1,127	559.24	402.75
Accounts Payable	7.83	0.48	0.94	0.66	5.49
Deferred Revenue	0	0	0	0	0.88
Current Debt	202.69	3.08	121.3	3.13	1.15
Other Current Liabilities	65.59	21.96	39.46	28.38	33.42
Total Current Liabilities	276.1	25.53	161.7	32.17	40.93
Long-Term Debt	512.85	412.85	355.82	462.66	454.34
Other Long-Term Liabilities	28.42	9.77	3.5	1.76	0.73
Total Long-Term Liabilities	541.27	422.62	359.32	464.43	455.07
Total Liabilities	817.37	448.14	521.02	496.6	496
Total Debt	715.54	415.93	477.12	465.79	455.48
Debt Growth	72.03%	-12.82%	2.43%	2.26%	1.74%
Retained Earnings	-1,698.62	-696.38	-937.61	-1,466.06	-1,572.23
Comprehensive Income	-3.03	0	0	0	0
Shareholders' Equity	-346.3	652.38	605.91	62.64	-93.25
Net Cash / Debt	-623.38	241.52	144.26	-101.49	-277.21
Net Cash / Debt Growth	-	67.42%	-	-	-
Net Cash Per Share	-4.01	1.30	0.88	-0.63	-1.78
Working Capital	-42.81	755.1	583.53	463.67	265.92
Book Value Per Share	-2.23	4.23	3.73	0.39	-0.60

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).